2,578
Views
25
CrossRef citations to date
0
Altmetric
Research Article

Enhanced anti-hepatocarcinoma efficacy by GLUT1 targeting and cellular microenvironment-responsive PAMAM–camptothecin conjugate

, , , , , , & show all
Pages 153-165 | Received 02 Oct 2017, Accepted 17 Dec 2017, Published online: 28 Dec 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Bing Xu, Mengmeng Yan, Fei Zhou, Desheng Cai, Wenbo Guo, Xiaohui Jia, Runping Liu, Tao Ma, Tong Li, Feng Gao, Penglong Wang & Haimin Lei. (2021) Prostate-Specific Membrane Antigen and Esterase Dual Responsive Camptothecin–Oligopeptide Self-Assembled Nanoparticles for Efficient Anticancer Drug Delivery. International Journal of Nanomedicine 16, pages 7959-7974.
Read now
Wenhua Li, Zhong Chen, Xiaoying Liu, Mingming Lian, Haisheng Peng & Changmei Zhang. (2021) Design and evaluation of glutathione responsive glycosylated camptothecin nanosupramolecular prodrug. Drug Delivery 28:1, pages 1903-1914.
Read now
Weiwei Wang, Junting Fan, Guang Zhu, Jing Wang, Yumei Qian, Hongxia Li, Jianming Ju & Lingling Shan. (2020) Targeted Prodrug-Based Self-Assembled Nanoparticles for Cancer Therapy. International Journal of Nanomedicine 15, pages 2921-2933.
Read now
Pengkai Ma, Jianhua Chen, Haixian Qu, Ye Li, Xiaohui Li, Xuemei Tang, Zhigang Song, Hainan Xin, Jinbang Zhang, Jingxue Nai, Zhiping Li & Zhijun Wang. (2020) Hypoxic targeting and activating TH-302 loaded transcatheter arterial embolization microsphere. Drug Delivery 27:1, pages 1412-1424.
Read now
Yanping Lu, Shunping Han, Hongyue Zheng, Rui Ma, Yuting Ping, Jiafeng Zou, Hongxia Tang, Yongping Zhang, Xiuling Xu & Fanzhu Li. (2018) A novel RGDyC/PEG co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting delivery system. International Journal of Nanomedicine 13, pages 5937-5952.
Read now

Articles from other publishers (20)

Yinghua Wu, Junfeng Zhang, Wen He, Chenchen Li & Yanli Wang. (2023) Nanomaterials for Targeting Liver Disease: Research Progress and Future Perspectives. Nano Biomedicine and Engineering.
Crossref
Chen Shen, Mei Li, Yujuan Duan, Xin Jiang, Xiaoming Hou, Fulai Xue, Yinan Zhang & Yao Luo. (2023) HDAC inhibitors enhance the anti-tumor effect of immunotherapies in hepatocellular carcinoma. Frontiers in Immunology 14.
Crossref
Huan An, Xuehui Deng, Fang Wang, Pingcui Xu & Nani Wang. (2023) Dendrimers as Nanocarriers for the Delivery of Drugs Obtained from Natural Products. Polymers 15:10, pages 2292.
Crossref
Mahsa Sedighi, Zahra Mahmoudi, Samin Abbaszadeh, Mohammad Reza Eskandari, Morvarid Saeinasab & Farshid Sefat. (2023) Nanomedicines for hepatocellular carcinoma therapy: Challenges and clinical applications. Materials Today Communications 34, pages 105242.
Crossref
Søren Leth Mejlsøe & Jørn B. Christensen. 2023. Advanced and Modern Approaches for Drug Delivery. Advanced and Modern Approaches for Drug Delivery 357 387 .
Haiqin Huang, Lanlan Shao, Yan Chen, Weili Han, Yao Zhou, Tianqing Liu, Jinhua Gu & Hongyan Zhu. (2022) Sequential Dual Delivery System Based on siCOX-2-Loaded Gold Nanostar and Thermal-Sensitive Liposomes Overcome Hypoxia-Mediated Multidrug Resistance in Tumors. Molecular Pharmaceutics 19:7, pages 2390-2405.
Crossref
Chen Fu, Jingcan Qin, Xinlong Liu & Fei Kong. (2022) Galactosed and Reduction-Responsive Nanoparticles Assembled from Trimethylchitosan–Camptothecin Conjugates for Enhanced Hepatocellular Carcinoma Therapy. Pharmaceutics 14:7, pages 1315.
Crossref
Guijie Wei, Jianhua Chen, Ziqi Jing, Yanyi Li, Zhihui Li, Wei Zheng, Xiurui Sun, Wenwen Zhao, Zhe Zhang, Xue Wang, Hongcui Han, Chu Li, Yujie Zhang & Pengkai Ma. (2022) Glucose transporter 1 (GLUT1)-targeting and hypoxia-activated mitochondria-specific chemo-thermal therapy via a glycosylated poly(amido amine)/celastrol (PAMAM/Cel) complex. Journal of Colloid and Interface Science 608, pages 1355-1365.
Crossref
Feng Hu, Hailin Lu, Zishuo Ye, Shoujing Zhang, Wenbo Wang & Li Gao. (2021) Slow-release lubrication of artificial joints using self-healing polyvinyl alcohol/polyethylene glycol/ graphene oxide hydrogel. Journal of the Mechanical Behavior of Biomedical Materials 124, pages 104807.
Crossref
Mohamed Fawzi Kabil, Maha Nasr & Ibrahim M. El-Sherbiny. (2021) Conventional and hybrid nanoparticulate systems for the treatment of hepatocellular carcinoma: An updated review. European Journal of Pharmaceutics and Biopharmaceutics 167, pages 9-37.
Crossref
Selvaraj Kunjiappan, Parasuraman Pavadai, Sivakumar Vellaichamy, Sureshbabu Ram Kumar Pandian, Vigneshwaran Ravishankar, Ponnusamy Palanisamy, Saravanan Govindaraj, Gowshiki Srinivasan, Adhvitha Premanand, Murugesan Sankaranarayanan & Panneerselvam Theivendren. (2020) Surface receptor‐mediated targeted drug delivery systems for enhanced cancer treatment: A state‐of‐the‐art review. Drug Development Research 82:3, pages 309-340.
Crossref
Yilan Huang, Yiheng Huang, Yuefei Zhu, Xiaowen Zhu & Zhiqing Pang. 2021. Biomedical Composites. Biomedical Composites 167 200 .
Chunyue Wang, Zhong Chen, Xuefeng Tang, Xiaoying Liu, Wang Na, Wenhua Li & Ting Liu. (2020) Influences of galactose ligand on the uptake of TADF liposomes by HepG2 cells. Photodiagnosis and Photodynamic Therapy 32, pages 102014.
Crossref
Gabriel Martínez-Edo, Cristina Fornaguera, Salvador Borrós & David Sánchez-García. (2020) Glycyrrhetinic Acid-Functionalized Mesoporous Silica Nanoparticles for the Co-Delivery of DOX/CPT-PEG for Targeting HepG2 Cells. Pharmaceutics 12:11, pages 1048.
Crossref
Zhong Chen, Wenhua Li, Liwang Shi, Lei Jiang, Minghui Li, Changmei Zhang & Haisheng Peng. (2020) Kidney-targeted astaxanthin natural antioxidant nanosystem for diabetic nephropathy therapy. European Journal of Pharmaceutics and Biopharmaceutics 156, pages 143-154.
Crossref
Xin Wang, Lu Yang, Qin Fang, Jiaxi Xu, Xu Cheng, Yanbing Xue & Rupei Tang. (2020) GLUT1‐Targeting and GSH‐Responsive DOX/L61 Nanodrug Particles for Enhancing MDR Breast Cancer Therapy. Particle & Particle Systems Characterization 37:9, pages 2000165.
Crossref
Dominika Wrobel, Monika Müllerová, Tomáš Strašák, Květoslav Růžička, Michal Fulem, Radka Kubíková, Maria Bryszewska, Barbara Klajnert-Maculewicz & Jan Malý. (2020) Glucose-modified carbosilane dendrimers: Interaction with model membranes and human serum albumin. International Journal of Pharmaceutics 579, pages 119138.
Crossref
Caiyan Liu, Shenshen Yang, Kailong Wang, Xiaomei Bao, Yiman Liu, Shiyue Zhou, Hongwei Liu, Yuling Qiu, Tao Wang & Haiyang Yu. (2019) Alkaloids from Traditional Chinese Medicine against hepatocellular carcinoma. Biomedicine & Pharmacotherapy 120, pages 109543.
Crossref
Anisha Mazumder, Wirat Assawapanumat, Anupma Dwivedi, Somrudee Reabroi, Arthit Chairoungdua & Norased Nasongkla. (2019) Glucose targeted therapy against liver hepatocellular carcinoma: In vivo study. Journal of Drug Delivery Science and Technology 49, pages 502-512.
Crossref
John M. Tomich, Emily Wessel, Jiyeong Choi & L. Adriana Avila. 2019. Nucleic Acid Nanotheranostics. Nucleic Acid Nanotheranostics 247 276 .